Open Source Pharma Foundation in the News
Why a Century-Old Vaccine Offers New Hope Against Pathogens
"The century-old BCG tuberculosis vaccine, accessible to billions, trusted by billions, and which costs only 15 cents a dose, shows 92% efficacy against COVID-19 in very small clinical trial by Professor Denise Faustman of Harvard Medical School. It is thought that the vaccine boosts the overall immune system. This exemplifies OSPF's 2+ year exploration of certain off patent vaccines, including BCG, against COVID-19, future pandemics and other diseases - a new scientific and legal/economic paradigm for vaccines. We cannot guarantee that they will work, but we absolutely must explore them. The New York Times article mentions OSPF. 'Imagine if we could use existing vaccines to curb pandemics — that would change world history,' Mr. Menon said."
Beyond the Booster Shot
"In 2016, Jaykumar Menon, a human-rights lawyer based in New York, founded the Open Source Pharma Foundation to address market failures in drug development... One of its goals is to create new vaccines that leverage trained immunity for what it calls 'ultra-broad spectrum' coverage."
How open-source medicine could prepare us for the next pandemic
"The old drug discovery system was built to benefit shareholders, not patients. But a new, Linux-like platform could transform the way medicine is developed—and energize the race against COVID-19."
Why open source pharma is the path to both new and cheaper medicines
“There has been a lot of talk about alternative ways of doing things. Ways of bringing medicines to market that are different and which might plug some of the gaps we face.”
We should own our own livelihood and our own dream
"Open source research collaborations are an important and timely strategy to advance and possibly accelerate medical innovation," she says, "including in the area of neglected diseases where knowledge sharing is even more critical than in other fields. [...] When she came across an online "virtual laboratory" enabling researchers to carry out important work from home, she jumped at the chance to get involved..."
Can open-source drug development deliver?
“That’s why OSPF’s first clinical trials will focus on repurposed drugs; some existing drugs developed for one disease often show promise against others (an epileptic drug might work against tuberculosis, for instance).”
Tata Trusts Support OSPF — the ‘Linux for drugs’
“The initiative borrows from the Linux model, where it is end-to-end open source, and publically funded. So data is made public at every stage for academics, non- governmental organisations, communities or drug companies to get involved and work on a research lead.”
Open Source Covid Movement: A Non-Capitalist Alternative to Covid Control
"In many countries, open source activists are trying to find software to track people with Covid via mobile phone without losing privacy. In collaboration with the European Vaccine Initiative etc. The Open Source Pharma Foundation has started research on Covid vaccine discovery."